CORRELATION BETWEEN MICROPERIMETRY AND IMAGING IN EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN-LIKE APPEARANCE

Author:

Romano Francesco12ORCID,Boon Camiel J. F.34,Invernizzi Alessandro15,Bosello Francesca6,Casati Stefano6,Zaffalon Chiara16,Riva Ester1,Bertoni Alice Ingrid1,Agarwal Aniruddha7,Kalra Gagan8,Cozzi Mariano1,Staurenghi Giovanni1,Salvetti Anna Paola1

Affiliation:

1. Eye Clinic, Department of Biomedical and Clinical Science, Luigi Sacco Hospital, University of Milan, Milan, Italy;

2. Harvard Retinal Imaging Laboratory, Mass Eye and Ear, Boston, Massachusetts;

3. Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands;

4. Department of Ophthalmology, Amsterdam University Medical Center, Amsterdam, the Netherlands;

5. Department of Ophthalmology, Save Sight Institute, University of Sydney, Sydney, NSW, Australia;

6. Ophthalmic Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy;

7. Eye Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates; and

8. Cleveland Clinic, Cole Eye Institute, Cleveland, Ohio.

Abstract

Purpose: To determine the correlation between microperimetry and imaging findings in extensive macular atrophy with pseudodrusen-like appearance (EMAP). Methods: This cross-sectional, observational study included 44 consecutive patients with EMAP (88 eyes) and 30 healthy subjects (60 eyes). Both groups underwent visual acuity assessment, mesopic and scotopic microperimetry, fundus photography, autofluorescence, optical coherence tomography, and optical coherence tomography angiography. Retinal sensitivity was also subdivided in macular (0–4°) and paramacular areas (8–10°). Scotopic sensitivity loss was defined as the difference between scotopic and mesopic sensitivities for each tested point. Eyes with EMAP were further classified into the three stages described by Romano et al: 19 eyes in Stage 1, 31 in Stage 2, and 38 in Stage 3. Results: Mesopic and scotopic retinal sensitivity were significantly reduced in patients with EMAP compared with controls, particularly in the macular area (all P < 0.001). Mesopic retinal sensitivity progressively declined in more advanced EMAP stages (all P < 0.01), but no scotopic differences were observed between Stages 2 and 3 (P = 0.08). Remarkably, scotopic sensitivity loss was significantly higher in Stage 1 (P < 0.05). On multivariate analysis, mesopic dysfunction was associated with larger atrophic areas (P < 0.01), foveal involvement (P = 0.03), and fibrosis (P = 0.02). Conversely, no independent variable was associated with a reduced scotopic retinal sensitivity (all P > 0.05). Conclusion: The findings highlight that patients with EMAP suffer from a severe cone- and rod-mediated dysfunction on microperimetry. The predominant rod impairment in the early cases (Stage 1) emphasizes the importance of dark-adapted scotopic microperimetry as a clinical end point and suggests defective transportation across the RPE–Bruch membrane complex in its pathogenesis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference30 articles.

1. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity;Hamel;Am J Ophthalmol,2009

2. Clinical characteristics and risk factors of extensive macular atrophy with pseudodrusen: the EMAP case-control national clinical trial;Douillard;Ophthalmology,2016

3. Progression of atrophy and visual outcomes in extensive macular atrophy with pseudodrusen-like appearance;Romano;Ophthalmol Sci,2021

4. Multimodal imaging of extensive macular atrophy with pseudodrusen-like appearance;Romano;Ophthalmol Retina,2023

5. Natural course and classification of extensive macular atrophy with pseudodrusen-like appearance;Romano;Retina,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3